The current state of molecular testing in the treatment of patients with solid tumors, 2019.

When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.

Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey.

Phase III trials in ovarian cancer: The evolving landscape of front line therapy.

Complete surgical resection of isolated recurrent high-grade epithelial ovarian cancer in highly selected patients without chemotherapy is associated with an excellent outcome.

Author's Reply.

Accuracy of Intraoperative Frozen Section Diagnosis of Borderline Ovarian Tumors by Hospital Type.

Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer.

Complete Resection Is Essential in the Surgical Treatment of Gestational Trophoblastic Neoplasia.

A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).